These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 2453680

  • 1. Identification of cross-reactive and serotype 2-specific neutralization epitopes on VP3 of human rotavirus.
    Taniguchi K, Maloy WL, Nishikawa K, Green KY, Hoshino Y, Urasawa S, Kapikian AZ, Chanock RM, Gorziglia M.
    J Virol; 1988 Jul; 62(7):2421-6. PubMed ID: 2453680
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cross-reactive and serotype-specific neutralization epitopes on VP7 of human rotavirus: nucleotide sequence analysis of antigenic mutants selected with monoclonal antibodies.
    Taniguchi K, Hoshino Y, Nishikawa K, Green KY, Maloy WL, Morita Y, Urasawa S, Kapikian AZ, Chanock RM, Gorziglia M.
    J Virol; 1988 Jun; 62(6):1870-4. PubMed ID: 2452893
    [Abstract] [Full Text] [Related]

  • 7. Operational overlapping of cross-reactive and serotype-specific neutralization epitopes on VP7 of human rotavirus serotype 3.
    Kobayashi N, Taniguchi K, Urasawa S.
    Arch Virol; 1991 Jun; 117(1-2):73-84. PubMed ID: 1706592
    [Abstract] [Full Text] [Related]

  • 8. Analysis of the newly identified neutralization epitopes on VP7 of human rotavirus serotype 1.
    Kobayashi N, Taniguchi K, Urasawa S.
    J Gen Virol; 1991 Jan; 72 ( Pt 1)():117-24. PubMed ID: 1703558
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Preparation and characterization of a neutralizing monoclonal antibody directed to VP4 of rotavirus strain K8 which has unique VP4 neutralization epitopes.
    Kobayashi N, Taniguchi K, Urasawa T, Urasawa S.
    Arch Virol; 1991 Jan; 121(1-4):153-62. PubMed ID: 1722090
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mapping of antigenic sites involved in serotype-cross-reactive neutralization on group A rotavirus outercapsid glycoprotein VP7.
    Hoshino Y, Nishikawa K, Benfield DA, Gorziglia M.
    Virology; 1994 Feb 15; 199(1):233-7. PubMed ID: 8116249
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Characteristics and location of cross-reactive and serotype-specific neutralization sites on VP7 of human G type 9 rotaviruses.
    Kirkwood C, Masendycz PJ, Coulson BS.
    Virology; 1993 Sep 15; 196(1):79-88. PubMed ID: 8395127
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Analysis by plaque reduction neutralization assay of intertypic rotaviruses suggests that gene reassortment occurs in vivo.
    Hoshino Y, Sereno MM, Midthun K, Flores J, Chanock RM, Kapikian AZ.
    J Clin Microbiol; 1987 Feb 15; 25(2):290-4. PubMed ID: 2434522
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.